Product
Candidate(s)
FTH-001/003
(Serabelisib +
Sapanisertib)
Mechanism of Action
PI3K-alpha inhibitor & dual mTORC1/2 inhibitor (PIKTOR)
Indication
Advanced endometrial cancer
Preclinical
Phase 1
Phase 2
Phase 3
Indication
Other undisclosed solid tumors